 CAMBRIDGE, Mass., Aug. 03, 2021 GLOBE NEWSWIRE -- Beam Therapeutics Inc. Nasdaq: BEAM, a biotechnology company developing precision genetic medicines through base editing, today announced that Giuseppe Ciaramella, Ph.D., president and chief scientific officer of Beam, will participate in a panel titled, So Let it Be ReWritten - Updates in Gene Modulation during the 2021 Wedbush PacGrow Healthcare Conference on Tuesday, Aug. 10, 2021 at 9:10 a.m. ET. 